COMMUNIQUÉS West-GlobeNewswire

Aveanna to Participate at the RBC 2025 Global Healthcare Conference

29/04/2025 - 13:30

ATLANTA, April 29, 2025 (GLOBE NEWSWIRE) -- Aveanna Healthcare Holdings Inc. (“Aveanna”) (NASDAQ: AVAH) today announced that its management team will attend the RBC 2025 Global Healthcare Conference in New York on May [...]

Ocugen to Present on Modifier Gene Therapy Platform at Association for Research in Vision and Ophthalmology 2025 Annual Meeting and Retina World Congress

29/04/2025 - 13:30

MALVERN, Pa., April 29, 2025 (GLOBE NEWSWIRE) -- Ocugen, Inc. (Ocugen or the Company) (NASDAQ: OCGN), a pioneering biotechnology leader in gene therapies for blindness diseases, today announced that the Company will [...]

Olon Group renforce son leadership dans la bioproduction avec deux nominations stratégiques en France

29/04/2025 - 13:44

MILAN, 29 avr. 2025 (GLOBE NEWSWIRE) -- Olon Group, acteur mondial de référence dans les services CDMO pharmaceutiques, annonce la nomination de Jérôme Bédier comme PDG de ses entités françaises, et d’Andrea Conforto [...]

Aurora Spine Corporation Announces Fourth Quarter and Fiscal Year 2024 Financial Results

29/04/2025 - 13:48

- Company reports record revenue of $17.6 million for FY 2024, an increase of 21% – - Company to host conference call Today, Tuesday, April 29 th at 11am ET/8am PT – NOT FOR DISTRIBUTION IN THE UNITED STATES OR OVER [...]

ZyVersa Therapeutics Announces Published Data Showing Inflammasome ASC Inhibitor IC 100 Decreases Microglial Inflammasome Activation and Alpha-Synuclein That Contribute to Neurodegeneration in Parkinson’s Disease

29/04/2025 - 13:57

Study supported by the Michael J. Fox Foundation through a grant awarded to ZyVersa and leading inflammasome experts at University of Miami Miller School of Medicine who conducted the study. Parkinson’s Disease (PD) [...]

Solid Biosciences to Present at the American Society of Gene and Cell Therapy’s 28th Annual Meeting

29/04/2025 - 14:00

CHARLESTOWN, Mass., April 29, 2025 (GLOBE NEWSWIRE) -- Solid Biosciences Inc. (Nasdaq: SLDB), a life sciences company developing precision genetic medicines for neuromuscular and cardiac diseases, will present data from [...]

Apyx Medical Corporation Announces Two Peer-Reviewed Publications on the Use of Renuvion in Abdominal Body Contouring Procedures

29/04/2025 - 14:00

Two studies report favorable clinical outcomes and safety data for Renuvion ® when used during procedures that include lipoabdominoplasty for the treatment of loose and lax skin Rapid weight loss due to GLP-1 drugs [...]

iCAD Collaborates with Microsoft to provide access to its Mammography Solutions in Microsoft’s Precision Imaging Network (PIN)

29/04/2025 - 14:00

iCAD collaborates with Microsoft to offer radiology providers the option for automated patient reporting on mammography results through PowerScribe integration NASHUA, N.H., April 29, 2025 (GLOBE NEWSWIRE) -- iCAD, Inc [...]

Immutep Quarterly Activities Report Q3 FY25

29/04/2025 - 14:00

Media Release First patient safely dosed in TACTI-004 Phase III lung cancer trial, marking a significant milestone Pivotal TACTI-004 trial design presented at the European Lung Cancer Congress (ELCC) 2025 Patient [...]

Monopar Announces ALXN1840 Data Selected for Late-Breaker Presentation at EASL Congress 2025

29/04/2025 - 14:00

WILMETTE, Ill., April 29, 2025 (GLOBE NEWSWIRE) -- Monopar Therapeutics Inc. (Nasdaq: MNPR), a clinical-stage biopharmaceutical company focused on developing innovative treatments for patients with unmet medical needs, [...]

Incyclix Bio Granted U.S. FDA Fast Track Designation for INX-315 to Treat CCNE1-Amplified Platinum-Resistant/Refractory Ovarian Cancer

29/04/2025 - 14:00

Fast Track designation highlights potential of INX-315 to address unmet need for patients with recurrent advanced/metastatic cancer RESEARCH TRIANGLE PARK, N.C., April 29, 2025 (GLOBE NEWSWIRE) -- Incyclix Bio, LLC, a [...]

Breaking new ground in mental health research: Oxford University, Boehringer Ingelheim, and Cumulus Neuroscience launch first of its kind study investigating the day-to-day experience of patients with psychiatric disorders

29/04/2025 - 14:00

Ingelheim, Germany, Oxford and Belfast, UK, April 29, 202 5   – Boehringer Ingelheim, the University of Oxford , and Cumulus Neuroscience are joining forces to provide insights into the day-to-day experiences of people [...]

Statement re Grant of Options and Warrants

29/04/2025 - 08:00

DXS INTERNATIONAL PLC (AQSE: DXSP) Granting of Share Options and Warrants The Board of DXS International plc (the “Company” or “DXSP), the AQSE Growth Market quoted clinical decision support developer and supplier of [...]

deepull secures oversubscribed €50 million Series C financing to advance UllCORE diagnostic system for direct-from-blood rapid pathogen detection

29/04/2025 - 09:30

deepull secures oversubscribed €50 million Series C financing to advance UllCORE diagnostic system for direct-from-blood rapid pathogen detection Round co-led by Columbus Venture Partners, Panakès Partners and Mérieux [...]

DEBRA Research Announces Impact Investment into Nova Anchora to Advance Protein Therapy for Epidermolysis Bullosa

29/04/2025 - 10:00

Additional investors include global investment firm Viking Global Investors, charity foundation CureEB, the Epidermolysis Bullosa Medical Research Foundation (EBMRF), and Stanford University. The financing will enable [...]

L’entreprise de biotechnologie britannique Stablepharma Ltd. lance en première mondiale un essai de Phase I ciblé sur un vaccin thermostable contre le tétanos et la diphtérie

29/04/2025 - 10:36

LONDRES, 29 avr. 2025 (GLOBE NEWSWIRE) -- Après avoir obtenu l’autorisation de la MHRA, l’autorité britannique de réglementation du marché des dispositifs médicaux, Stablepharma Ltd. entre en essai clinique de Phase I [...]

Lumineye Introduces Sublingual Nano-Drop Formula to Help Support Normal Eye Comfort and Clarity

29/04/2025 - 06:18

Sheridan, Wyoming, USA, April 29, 2025 (GLOBE NEWSWIRE) -- Lumineye , a pioneering company in the health and wellness sector, today announced the launch of its new product: The Lumineye Nanodrop. This advanced dietary [...]

Roche granted FDA Breakthrough Device Designation for first AI-driven companion diagnostic for non-small cell lung cancer

29/04/2025 - 07:00

The VENTANA TROP2 (EPR20043) RxDx Device is an immunohistochemistry (IHC) assay combined with a digital pathology algorithm to determine patient treatment. The device uses artificial intelligence-based image analysis [...]

Santhera Full Year Results for the Year Ended 31 December 2024

29/04/2025 - 07:00

Transformational year following the successful launch of AGAMREE® Pratteln, Switzerland, April 29, 2025 – Santhera Pharmaceuticals (SIX: SANN) today announces its full year results for the year ended 31 December 2024. [...]